Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06636240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 25, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint revised
    • Start date changed from estimate of Apr 1, 2025 to Mar 17, 2025
    • Interventions: Fluticasone (Other), Mulberry fruit juice (Dietary Supplement) to Mometasone furoate 0.1% cream (Other), Mulberry fruit juice (Dietary Supplement)
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 1, 2025 to Feb 1, 2026
    • Start date: Nov 1, 2024 to Apr 1, 2025
    • Study sites: 1 to 2
    • Study completion date: Apr 30, 2025 to Apr 30, 2026
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project proposes a randomized controlled human study to explore the prebiotic effects of consuming mulberry juice on atopic dermatitis in children and adolescents. The study aims to investigate the potential of mulberry fruit as a human prebiotic. This human study will recruit up to 120 participants from the Taipei Medical University Hospital (commissioned by the Ministry of Health and Welfare). Participants will be divided into experimental groups and a control group, with a 3-month intervention involving five clinical assessments and three stool collections. The goal is to compare the severity of atopic dermatitis, gut microbiota, and metabolite changes during the 6 days of mulberry juice consumption between the experimental and control groups. This project will help establish mulberry fruit as a potential human prebiotic and adjunctive treatment for alleviating atopic dermatitis in children.
Trial Details
NCT Number NCT06636240
Lead Sponsor Taipei Medical University Shuang Ho Hospital
Conditions
(from sponsor)		 Atopic Dermatitis (Eczema), Atopic Dermatitis, Probiotics
Related terms Dermatitis, Atopic, Eczema
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov